Beukelman, Timothy G., MD, MSCE

Beukelman mug 04 2014 1 crop

Associate Professor, Division of Pediatric Rheumatology
Department of Pediatrics

Secondary Appointment: Division of Clinical Immunology & Rheumatology

 

Address:

Children's Park Place, Suite 210
1601 4th Avenue South
Birmingham, AL 35233-1711

 

Telephone:205-638-9438
Email: tbeukelman@peds.uab.edu

 

Education

BS, University of Illinois, Urbana-Champaign, IL, 1997
MD, Washington University, Saint Louis, MO, 2001
Intern (Pediatrics): Cincinnati Children’s Hospital Medical Center, OH, 2002
Resident (Pediatrics): Cincinnati Children’s Hospital Medical Center, OH, 2004
Fellow (Pediatric Rheumatology):The Children’s Hospital of Philadelphia, PA, 2007
M.S.C.E., University of Pennsylvania, Philadelphia, PA, 2008

 

Awards and Honors

2013 ACR/EULAR International Academic Rheumatology Exchange, Early Career Investigator Delegate

2013 Member, American Pediatric Society

 

Research Description

Optimizing the treatment of juvenile idiopathic arthritis using various clinical research methods including retrospective analysis of observational data, prospective observational data collection and analysis, decision analysis, and clinical trials..

 

Publications

Click here for a complete list of publications in PubMed. A few selected papers are below

Mannion ML, Xie F, Curtis JR, Beukelman T. 2014. Recent trends in medication usage for the treatment of juvenile idiopathic arthritis and the influence of tumor necrosis factor inhibitors. J Rheumatol 41:2078-84. PMID: 25086081


Shafferman A, Fontaine KR, Cron RQ, Beukelman T. 2014. Changes in body mass index in children with juvenile idiopathic arthritis treated with tumor necrosis factor inhibitors. J Rheumatol 41:113-8. PMID: 24293573


Lionetti G, Kimura Y, Schanberg LE, Beukelman T, Wallace C, Ilowite N, Winsor J, Fox K, Natter M, Sundy JS, Brodsky E, Curtis JR, Del Gaizo V, Iyasu S, Jahreis A, Meeker-O’Connell A, Mittleman BB, Murphy BM, Peterson ED, Raymond SC, Setoguchi S, Siegel JN, Sobel RE, Solomon D, Southwood TR, Vesely R, White PH, Wulfraat NM, Sandborg CI. 2013. Using registries to identify adverse events in rheumatic diseases. Pediatrics 132:e1384-94. PMCID: PMC3813393


Winthrop KL, Baddley JW, Chen L, Liu L, Grijalva CG, Delzell E, Beukelman T, Patkar NM, Xie F, Saag KG, Herrinton LJ, Solomon DH, Lewis JD, Curtis JR. 2013. Association between the initiation of anti-tumor necrosis factor therapy and the risk of herpes zoster. JAMA  309:887-95. PMCID: PMC3773213


Beukelman T, Xie R, Baddley JW, Chen L, Delzell E, Grijalva CG, Mannion ML, Patkar NM, Saag KG, Winthrop KL, Curtis JR. 2013. Incidence of selected opportunistic infections among children with juvenile idiopathic arthritis. Arthritis Rheum  65:1384-9. PMCID: PMC3636167


Beukelman T, Ringold S, Davis TE, Morgan DeWitt E, Pelajo CF, Weiss PF, Kimura Y. 2012. Disease modifying anti-rheumatic drug use in the treatment of juvenile idiopathic arthritis: A cross-sectional analysis of the CARRA Registry. J Rheumatol  39:1867-74. PMCID: PMC3763075


Beukelman T, Curtis JR, Cutter G, Delzell E, Gary LC, Harrington TM, Karkare S, Kilgore ML, Lewis CE, Moloney R, Oliveira A, Singh J, Warriner A, Zhang J, Berger M, Cummings SR, Pace W, Solomon DH, Wallace R, Tunis SR. 2012.  Improving the efficiency and effectiveness of pragmatic clinical trials in older adults in the Unites States. Contemp Clin Trials  33:1211-6. [cited 5 times] PMCID: PMC3675785


Beukelman T, Xie F, Chen L, Baddley JW, Delzell E, Grijalva CG, Patkar NM, Saag KG, Winthrop KL, Curtis JR. 2012. Rates of hospitalized bacterial infection in juvenile idiopathic arthritis and its treatment. Arthritis Rheum  64:2773-80. PMCID: 3409300


Curtis JR, Xie F, Chen L, Munter P, Grijalva CG, Spettell C, Fernandes J, McMahan RM, Baddley JW, Saag KG, Beukelman T, Delzell E. 2012. Use of a disease risk score to compare serious infections associated with anti-TNF therapy among high versus lower risk rheumatoid arthritis patients. Arthritis Care Res 64: 1480-9. PMCID: PMC3687540


Beukelman T, Haynes K, Curtis JR, Xie F, Chen L, Bemrich-Stolz CJ, Delzell E, Saag KG, Solomon DH, Lewis JD. 2012. Rates of malignancy associated with juvenile idiopathic arthritis and its treatment. Arthritis Rheum  64:1263-7. PMCID: PMC3315602


Donnithorne KJ, Cron RQ, Beukelman T. 2011. Attainment of inactive disease status following initiation of TNFα inhibitor therapy in a heterogeneous cohort of children with juvenile idiopathic arthritis: Enthesitis related arthritis predicts persistent active disease. J Rheumatol  38:2675-81. PMCID: PMC3757922


Grijalva CG, Chen L, Delzell E, Baddley JW, Beukelman T, Winthrop KL, Griffin MR, Herrinton LJ, Liu L, Ouellet-Hellstrom R, Patkar NM, Solomon DH, Lewis JD, Xie F, Saag KG, Curtis JR. 2011. Initiation of tumor necrosis factor-α antagonists and the risk of hospitalization for infection in patients with autoimmune diseases. JAMA 306:2331-9. PMCID: PMC3428224


Herrinton LJ, Curtis JR, Chen L, Liu L, Delzell E, Lewis JD, Solomon DH, Griffin MR, Ouellet-Hellstom R, Beukelman T, Grijalva CG, Haynes K, Kuriya B, Lii J, Mitchel E Patkar NM, Rassen J, Winthrop KL, Nourjah P, Saag KG. 2011. Study design for a comprehensive assessment of biologic safety using multiple healthcare data systems. Pharmacoepidemiol Drug Saf  20:1199-209. PMCID: PMC3312584


Curtis JR, Xie F, Chen L, Baddley JW, Beukelman T, Saag K, Spettell C, McMahan RM, Fernandes J, Winthrop K, Delzell E. 2011.  The comparative risk of serious infections among rheumatoid arthritis patients starting or switching biologic agents. Ann Rheum Dis  70:1401-6. PMCID: PMC3128235


Beukelman T, Patkar NM, Saag KG, Tolleson-Rinehart S, Cron RQ, DeWitt EM, Ilowite NT, Kimura Y, Laxer RM, Lovell DJ, Martini A, Rabinovich CE, Ruperto N. 2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: initiation and safety monitoring of therapeutic agents for the treatment of arthritis and systemic features. Arthritis Care Res  63:465-82. PMCID: PMC3222233


Beukelman T, Saag KG, Curtis JR, Kilgore ML, Pisu M. 2010. Cost-effectiveness of multifaceted evidence implementation programs for the prevention of glucocorticoid-induced osteoporosis. Osteoporos Int ; 21:1573-84. PMCID: PMC3815619


Beukelman T, Guevara JP, Albert DA. 2008. Optimal treatment of knee monarthritis in juvenile idiopathic arthritis: a decision analysis. Arthritis Rheum  59:1580-88. PMID: 18975367


Beukelman T, Guevara JP, Albert DA, Sherry DD, Burnham JM. 2008. Usage of intra-articular corticosteroid injections for the treatment of juvenile idiopathic arthritis: a survey of pediatric rheumatologists in the United States and Canada. Clin Exp Rheumatol  26:700-3. PMID: 18799109


Beukelman T, Guevara JP, Albert DA, Sherry DD, Burnham JM. 2007. Variation in the initial treatment of knee monoarthritis in juvenile idiopathic arthritis: a survey of pediatric rheumatologists in the United States and Canada. J Rheumatol  34:1918-24. PMID: 17787051


Behrens EM, Beukelman T, Paessler M, Cron RQ. 2007. Occult macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis. J Rheumatol  34:1133-8. PMID: 17343315


Beukelman T, Arabshahi B, Cahill AM, Kaye RD, Cron RQ. 2006. Benefit of intraarticular corticosteroid injection under fluoroscopic guidance for subtalar arthritis in juvenile idiopathic arthritis. J Rheumatol  33:2330-6. PMID: 16981290

 

SOM Epilogue Menu